Multiple Site Testing Evaluation - Bayer HealthCare Ascensia Breeze User Manual

MULTIPLE SITE TESTING EVALUATION:

Forty-one subjects with diabetes participated in the study.
Subjects were in steady state for glucose (no insulin or oral
hypoglycemic medication; nothing to eat or drink, other than
water; and no vigorous exercise in the past two hours). The
subjects performed self-capillary blood glucose assays using
the Ascensia B
fingerstick was performed with the Microlet Adjustable
Lancing Device. Samples from the palm, forearm, thigh and
abdomen were obtained using the Microlet Vaculance
Lancing Device. Ascensia B
sites were compared to those obtained from the finger. The
blood glucose range for the fingerstick measurements was 60
to 245 mg/dL, with an average of 137 mg/dL. The hematocrit
range was 38 to 53%, with an average of 45%.
A. Results from Palm (n = 36)
350
300
250
200
150
100
50
0
0 50
Ascensia B
System and one test strip lot (Lot A). A
REEZE
y=x
100 150 200 250
Finger Stick Result (mg/dL)
REEZE
results from the multiple
REEZE
B. Results from Forearm (n = 30)
350
300
250
200
150
100
50
0
300 350
0 50 100 150
Ascensia B Finger Stick Result (mg/dL)
REEZE
y=x
200 250 300 350
37